Entero Therapeutics, Inc.

Biotechnology • Healthcare • Edinburgh, United Kingdom • ENTO (NGM)

Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.

91 George St, United Kingdom

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Entero Regains Nasdaq Compliance With Grid AI Acquisition - FDL Reporter | The Reporter - fdlreporter.com

fdlreporter.com • Jan 6

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - The Asheville Citizen Times

The Asheville Citizen Times • Dec 30

Entero Regains Nasdaq Compliance With Grid AI Acquisition - The Hutchinson News

The Hutchinson News • Jan 3

Entero Regains Nasdaq Compliance With Grid AI Acquisition - Victorville Daily Press

Victorville Daily Press • Jan 3

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - The Star Press

The Star Press • Dec 29

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Entero Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Entero Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Entero Therapeutics, Inc. in?

Entero Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Entero Therapeutics, Inc. a publicly traded company?

Yes, Entero Therapeutics, Inc. is publicly traded under the ticker symbol ENTO on the NGM. The company has a market capitalization of approximately $0.01 billion.

Where is Entero Therapeutics, Inc. headquartered?

Entero Therapeutics, Inc. is headquartered in Edinburgh, United Kingdom at 91 George St, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.